How Gudonis was paid
$1.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Paul R. GudonisChief Executive Officer | $375,000 | $600,072 | $208,611 | $17,500 | $1,201,183 |
| David A. HenryChief Financial Officer | $283,900 | $291,367 | $97,475 | $17,500 | $690,242 |
| Harry KovelmanChief Medical Officer | $283,662 | $238,489 | $78,312 | $7,335 | $607,798 |
What changed and why
- 1,201,183: CEO total compensation in 2025, compared with 1,240,467 in 2024.
- 51%51%: Each named executive achieved this percentage of the 2025 Corporate Bonus Amount.
- 60%60%/20%/20%: 2025 target bonuses weighted revenue, corporate metrics and subjective individual performance.
- 52%52%/32%/27%: Gudonis, Henry and Kovelman’s 2025 bonuses represented these percentages of base salary.
- 2025 bonuses: Each executive’s bonus will be paid as fully vested RSUs after the proxy filing.
- $31,411$31,411/$14,135/$11,356: Spending-target savings incentives for Gudonis, Henry and Kovelman.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.